One year after reports of supply chain issues, 49% of reports in the US and 34% of reports in Canada were associated with ...

Increased relative risk for adverse events seen among those admitted during weeks with high versus low COVID-19 burden ...

The FDA has issued a proposal to remove a common decongestant in over the counter products.

Credit: Journey Medical Corporation. The approval was supported by data from 2 randomized, double-blind, active- and ...

Full results from the trial will be presented at an upcoming medical meeting. Topline results from a phase 3 trial show that tezepelumab statistically significantly reduced the size of nasal polyps ...

The Orphan Drug designation was supported by preclinical research and preliminary data from the dose escalation/expansion phase 1/2 trial.

HealthDay News — The prevalence of diabetes was 15.8% among US adults during August 2021 to August 2023, according to a November data brief published by the National Center for Health Statistics.

The PDUFA target date is August 21, 2025. The Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for donidalorsen for the prophylactic treatment of hereditary ...

Clear cell hidradenoma is a tumor that results from overgrowth of either eccrine or apocrine sweat glands. Lesions are most ...

Early-life exposure to nitrogen dioxide, fine particulate matter linked to prevalence and persistence of peanut allergy ...

Board Chairman Kelly Aberasturi told the AP that while he’s skeptical of COVID vaccines, he was supportive of but “disappointed” in the board’s decision.